Does Genetic Testing Improve Prediction of Type 2 Diabetes?
Author Information
Author(s): Janssens ACJW, Gwinn M, Subramonia-Iyer S, Khoury MJ
Primary Institution: Erasmus University Medical Center Rotterdam
Hypothesis
Does testing for PPARG PP and CAPN10 SNP43/44 genotypes improve the prediction of T2D based on BMI and FPG alone?
Conclusion
Genetic testing for certain genotypes does not improve the prediction of type 2 diabetes when considering body mass index and fasting plasma glucose.
Supporting Evidence
- Genetic testing might identify individuals at risk of developing T2D.
- The hazard ratio of 21.2 was found in obese carriers of specific genotypes.
- The incidence of T2D was significantly higher in carriers of risk genotypes.
- Genotyping did not significantly alter the risk of T2D in other subgroups.
- The AUC for BMI and FPG alone was 0.68, indicating moderate accuracy.
- Adding genotype information did not improve the AUC for T2D prediction.
Takeaway
The study found that knowing your genes doesn't help much in predicting if you'll get diabetes if you already know your weight and blood sugar levels.
Methodology
Logistic regression was used to estimate T2D risks based on different prediction models including BMI, FPG, and genetic information.
Potential Biases
The focus on the highest-risk category may have skewed the interpretation of the genetic testing's effectiveness.
Limitations
The study did not account for follow-up time, age, and sex in its analysis.
Participant Demographics
Participants included individuals with varying body mass index and fasting plasma glucose levels.
Statistical Information
Confidence Interval
95% CI, 0.63–0.73
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website